Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma.

Saved in:
Bibliographic Details
Title: Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma.
Authors: Sulsenti R; Molecular Immunology Unit, Department of Research, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Frossi B; Immunology Section, Department of Medicine, University of Udine, Udine, Italy., Bongiovanni L; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Cancila V; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Ostano P; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, Biella, Italy., Fischetti I; Molecular Immunology Unit, Department of Research, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Enriquez C; Molecular Immunology Unit, Department of Research, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Guana F; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, Biella, Italy., Chiorino G; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, Biella, Italy., Tripodo C; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Pucillo CE; Immunology Section, Department of Medicine, University of Udine, Udine, Italy., Colombo MP; Molecular Immunology Unit, Department of Research, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy., Jachetti E; Molecular Immunology Unit, Department of Research, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy.
Source: Frontiers in immunology [Front Immunol] 2021 Mar 02; Vol. 12, pp. 622001. Date of Electronic Publication: 2021 Mar 02 (Print Publication: 2021).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2021.622001